| Product Code: ETC10603183 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Human Rabies Vaccines Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Human Rabies Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Human Rabies Vaccines Market - Industry Life Cycle |
3.4 Israel Human Rabies Vaccines Market - Porter's Five Forces |
3.5 Israel Human Rabies Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Israel Human Rabies Vaccines Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Human Rabies Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Human Rabies Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of rabies vaccination in Israel |
4.2.2 Growing investments in healthcare infrastructure and facilities |
4.2.3 Rising incidence of rabies cases in both humans and animals in the region |
4.3 Market Restraints |
4.3.1 High cost associated with human rabies vaccines |
4.3.2 Limited accessibility to vaccines in remote areas |
4.3.3 Regulatory challenges and stringent approval processes for new vaccines |
5 Israel Human Rabies Vaccines Market Trends |
6 Israel Human Rabies Vaccines Market, By Types |
6.1 Israel Human Rabies Vaccines Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Human Rabies Vaccines Market Revenues & Volume, By Vaccine Type, 2021 - 2031F |
6.1.3 Israel Human Rabies Vaccines Market Revenues & Volume, By Cell Culture Vaccines, 2021 - 2031F |
6.1.4 Israel Human Rabies Vaccines Market Revenues & Volume, By Nerve Tissue Vaccines, 2021 - 2031F |
6.1.5 Israel Human Rabies Vaccines Market Revenues & Volume, By Recombinant Vaccines, 2021 - 2031F |
6.2 Israel Human Rabies Vaccines Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Human Rabies Vaccines Market Revenues & Volume, By Post-exposure Prophylaxis, 2021 - 2031F |
6.2.3 Israel Human Rabies Vaccines Market Revenues & Volume, By Pre-exposure Prophylaxis, 2021 - 2031F |
6.3 Israel Human Rabies Vaccines Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Israel Human Rabies Vaccines Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.3.3 Israel Human Rabies Vaccines Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.3.4 Israel Human Rabies Vaccines Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 Israel Human Rabies Vaccines Market Import-Export Trade Statistics |
7.1 Israel Human Rabies Vaccines Market Export to Major Countries |
7.2 Israel Human Rabies Vaccines Market Imports from Major Countries |
8 Israel Human Rabies Vaccines Market Key Performance Indicators |
8.1 Percentage increase in the number of rabies vaccinations administered annually |
8.2 Adoption rate of new and advanced rabies vaccine technologies in Israel |
8.3 Number of reported rabies cases in humans and animals in the region |
9 Israel Human Rabies Vaccines Market - Opportunity Assessment |
9.1 Israel Human Rabies Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Israel Human Rabies Vaccines Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Human Rabies Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Human Rabies Vaccines Market - Competitive Landscape |
10.1 Israel Human Rabies Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Israel Human Rabies Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here